Zencast-D Tablet is a combination pharmaceutical formulation containing Trypsin (48mg), Bromelain (90mg), Rutoside (100mg), and Diclofenac (50mg), designed to provide effective anti-inflammatory, analgesic, and fibrinolytic effects. Trypsin and Bromelain are proteolytic enzymes that facilitate the breakdown of proteins, promoting the reduction of edema and inflammation by enhancing the absorption of inflammatory exudates. Rutoside, a bioflavonoid, contributes to vascular protection by strengthening capillary walls and reducing capillary permeability, thereby minimizing bruising and swelling. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts potent analgesic and anti-inflammatory actions by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), leading to decreased prostaglandin synthesis. The synergistic effect of these components makes Zencast-D Tablet particularly beneficial in managing acute musculoskeletal conditions such as sprains, strains, contusions, and post-operative inflammation. It is indicated for the relief of pain, inflammation, and swelling associated with trauma or surgery. Zencast-D should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active gastrointestinal ulcers, or bleeding disorders. Appropriate dosing and duration of therapy are essential to maximize therapeutic benefits while minimizing potential adverse effects.